Cellmid to commence selling of evolis into Chinese market
Filed with ASX · · 3 pages · English
Earlier from Anagenics
- Cellmid secures Bloomingdales USA partnership for evolis
- Appendix 4C - quarterly
- Cellmid signs distribution agreement for Fillerina
- Appendix 4D and Half Year Accounts
- Record 2M sales for Cellmid FGF5 inhibitors
Later from Anagenics
- Cellmid updates on distribution of evolis
- Cellmid Share Placement Raises $9M
- Cellmid Share Purchase Plan
- Cleansing Notice and Appendix 3B
- Preliminary Final Report
Follow Anagenics into a list and get an email when it puts out news.
Follow Anagenics